Taiyen Biotech Co Ltd (1737) — Free Cash Flow Generation Index
Taiyen Biotech Co Ltd (1737) has a Free Cash Flow Generation Index of 0.74x as of March 2026. Free cash flow of NT$129.04 Million represents 1% of operating cash flow (NT$173.44 Million). Read 1737 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Taiyen Biotech Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Taiyen Biotech Co Ltd across 23 annual periods. Explore 1737 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Taiyen Biotech Co Ltd. For the full company profile including market capitalisation, see Taiyen Biotech Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | NT$173.60 Million | NT$473.77 Million | NT$300.16 Million | ▼ -31.4% |
| 2024 | 0.53x | NT$352.51 Million | NT$660.12 Million | NT$307.61 Million | ▲ +121.9% |
| 2023 | 0.24x | NT$109.41 Million | NT$454.54 Million | NT$345.13 Million | ▼ -58.2% |
| 2022 | 0.58x | NT$334.09 Million | NT$580.69 Million | NT$246.60 Million | ▲ +65.0% |
| 2021 | 0.35x | NT$209.26 Million | NT$600.08 Million | NT$390.81 Million | ▲ +65.6% |
| 2020 | 0.21x | NT$71.46 Million | NT$339.36 Million | NT$267.89 Million | ▲ +49.6% |
| 2019 | 0.14x | NT$46.56 Million | NT$330.81 Million | NT$284.25 Million | ▼ -58.2% |
| 2018 | 0.34x | NT$151.35 Million | NT$449.83 Million | NT$298.49 Million | ▼ -14.1% |
| 2017 | 0.39x | NT$238.18 Million | NT$607.87 Million | NT$369.68 Million | ▼ -41.1% |
| 2016 | 0.67x | NT$377.77 Million | NT$568.06 Million | NT$190.30 Million | ▼ -7.9% |
| 2015 | 0.72x | NT$277.36 Million | NT$383.93 Million | NT$106.57 Million | ▲ +20.6% |
| 2014 | 0.60x | NT$222.25 Million | NT$371.06 Million | NT$148.81 Million | ▲ +11.0% |
| 2013 | 0.54x | NT$109.68 Million | NT$203.21 Million | NT$93.53 Million | ▲ +85.0% |
| 2012 | 0.29x | NT$45.06 Million | NT$154.46 Million | NT$109.40 Million | ▼ -57.6% |
| 2011 | 0.69x | NT$169.24 Million | NT$246.09 Million | NT$76.85 Million | ▲ +18.4% |
| 2010 | 0.58x | NT$174.81 Million | NT$300.89 Million | NT$126.08 Million | ▼ -14.5% |
| 2009 | 0.68x | NT$243.36 Million | NT$358.02 Million | NT$114.67 Million | ▼ -53.4% |
| 2008 | 1.46x | NT$609.60 Million | NT$417.51 Million | NT$192.08 Million | ▲ +17.1% |
| 2007 | 1.25x | NT$402.19 Million | NT$322.49 Million | NT$79.70 Million | ▼ -5.6% |
| 2006 | 1.32x | NT$611.33 Million | NT$462.88 Million | NT$148.45 Million | ▲ +7.9% |
| 2005 | 1.22x | NT$705.10 Million | NT$575.91 Million | NT$129.19 Million | ▲ +14.6% |
| 2004 | 1.07x | NT$3.03 Billion | NT$2.84 Billion | NT$192.93 Million | ▲ +3.9% |
| 2003 | 1.03x | NT$3.51 Billion | NT$3.42 Billion | NT$94.39 Million | — |